Echinacea root contains the highest levels of the immune stimulating alkylamides so Echinacea root preparations should be used when strong immune modulating activity is required.

Such indications would include:

• Prophylaxis and treatment of infectious conditions such as influenza, colds and septic processes, particularly those of a chronic or recurrent nature.
• Treatment of allergies, mild septicaemia, skin disorders such as psoriasis.
• To alleviate temporary weakness of the body’s defences; to reduce the immune depletion caused by chemotherapy.
• States of weakened or suppressed immunity such as post-viral syndromes.
• Autoimmune diseases

The three major groups of active constituents occurring in Echinacea are the caffeic acid derivatives, polysaccharides and the lipophilic components (mainly alkylamides and polyacetylenes).

The alkylamides cause a characteristic tingling in the mouth.

The level of certain active constituents can vary markedly (even being reduced to zero) depending upon the time of harvest and the quality of postharvest handling (especially drying).

The root contains:

• alkylamides: present in E. angustifolia (0.3–1.2%) and E. purpurea (0.3–0.8%) and largely absent from E. pallida;
• caffeic acid esters including echinacoside (0.4–1.0% in E. angustifolia, not present in E. purpurea), cichoric acid (significant quantities in E. purpurea only: 0.7–1.5%) and cynarin (in E. angustifolia only). The aerial parts contain alkylamides in smaller quantities than in the roots (0.01–0.03% in E. purpurea). The main caffeic acid ester present in E. purpurea flowering tops is cichoric acid (0.7–2.5%).

YWB – Immune Support  Contains :

• Astragalus membranaceous
• l-lysine
• ginseng
• egcg
• licorice
• N-acetyl-cysteine

Horsetail herb :

Post vaccination, contains silica which helps excrete aluminium